Insulet (PODD) Research & Development (2010 - 2026)
Insulet's (PODD) quarterly Research & Development came in at $89.7 million in Q1 2026, up 50.5% YoY from $59.6 million in Q1 2025, and down 1.32% on a QoQ basis from $90.9 million in Q4 2025.
Insulet (PODD) Research & Development (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Research & Development data on file, last reported at $89.7 million in Q1 2026.
- Quarterly Research & Development rose 50.5% year-over-year to $89.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $331.2 million (up 44.63% YoY) and the FY2025 annual result came in at $301.1 million, up 37.11% from the prior year.
- Research & Development slipped to $89.7 million in Q1 2026, from $90.9 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $90.9 million in Q4 2025 to a low of $42.0 million in Q4 2023.
- A 5-year average of $58.6 million and a median of $54.9 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development plunged 61.7% — and 2026, when it surged 50.5%.
- Tracing PODD's Research & Development over 5 years: stood at $49.5 million in 2022, then declined by 15.15% to $42.0 million in 2023, then surged by 44.29% to $60.6 million in 2024, then jumped by 50.0% to $90.9 million in 2025, then declined by 1.32% to $89.7 million in 2026.
- The last three Research & Development figures came in at $89.7 million (Q1 2026), $90.9 million (Q4 2025), and $77.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Insulet | 10.34 Bn | 9.81 Bn | 562.60 Mn | 88.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 88.10 Mn |
| Mar 31, 2026 | 89.70 Mn |
| Dec 31, 2025 | 90.90 Mn |
| Sep 30, 2025 | 77.20 Mn |
| Jun 30, 2025 | 73.40 Mn |
| Mar 31, 2025 | 59.60 Mn |
| Dec 31, 2024 | 60.60 Mn |
| Sep 30, 2024 | 54.90 Mn |
| Jun 30, 2024 | 53.90 Mn |
| Mar 31, 2024 | 50.20 Mn |
| Dec 31, 2023 | 42.00 Mn |
| Sep 30, 2023 | 57.80 Mn |
| Jun 30, 2023 | 55.10 Mn |
| Mar 31, 2023 | 50.10 Mn |
| Dec 31, 2022 | 49.50 Mn |
| Sep 30, 2022 | 45.00 Mn |
| Jun 30, 2022 | 42.60 Mn |
| Mar 31, 2022 | 43.10 Mn |
| Dec 31, 2021 | 41.80 Mn |
| Sep 30, 2021 | 117.50 Mn |